Madrid, May .
HRN: 12-76-53 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2025
CEFUROXIME 1.5GM (VIAL)
12/27/2025
12/27/2025
IV
1.5 G
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness
12/27/2025
CEFAZOLIN 1GM (VIAL)
12/27/2025
12/27/2025
IV
2g
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness
12/27/2025
CEFUROXIME 500MG (TAB)
12/27/2025
01/02/2026
ORAL
500mg
BID
Sp PLTCS
Checking Initial Appropriateness
12/27/2025
MUPIROCIN 2%, 15G (TUBE)
12/27/2025
01/02/2026
TOPICAL
15mg
BID X 7days
Sp PLTCS
Checking Initial Appropriateness